15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Genesco Inc, 0 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $38.00 to $38.00, so the covering firms are broadly aligned. The average target of $38.00 sits 10% above the current $34.58. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $4.24 next quarter toward $2.95 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Hold
Strong Buy00%
Buy00%
Hold2100%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Genesco Inc.
As of Sep, 0 of 2 firms rate GCO a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
GCO EPS & revenue forecast
EPS · NEXT QUARTER
$4.24
Range $4.15 – $4.42 · 4 analysts · +13% YoY
Next period, 4 analysts expect Genesco Inc to earn $4.24 a share (range $4.15 – $4.42), versus $3.74 a year earlier. Full-year consensus is $2.36, growing to $2.95 the year after.
REVENUE · NEXT QUARTER
$775.3M
Range $768.0M – $780.2M · 4 analysts · -3% YoY
Revenue is expected to reach $775.3M (range $768.0M – $780.2M), -3.1% year-over-year. Full-year consensus is $2.4B, rising to $2.4B next year.
Top analysts covering Genesco Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on GCO.
#1
JC
Joseph Civello
Truist Securities
Hold
$38.00+9.9% to target
Coverage
—
+ Follow
#2
MK
Mitch Kummetz
Seaport Global
Hold
$37.00+7.0% to target
Coverage
—
+ Follow
#3
Corey Tarlowe
Jefferies
Hold
$32.00-7.5% to target
Coverage
—
+ Follow
GCO stock forecast FAQ
What is GCO's average 12-month price target?+
The 1 analysts with a live target average $38.00 for Genesco Inc over the next 12 months, ranging from a $38.00 high to a $38.00 low.
Is GCO stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 2 analyst ratings, 0 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover GCO?+
2 analysts have an active rating on Genesco Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering GCO?+
Among analysts who currently cover GCO, Joseph Civello of Truist Securities has the strongest overall Quantellect track record. Their current call is Hold with a $38.00 target.
What is Genesco Inc's projected EPS for next quarter?+
The consensus estimate is $4.24 per share (range $4.15 – $4.42) across 4 analysts. Full-year EPS is projected at $2.36, rising to $2.95 the following year.
How much revenue is Genesco Inc expected to report next quarter?+
Consensus revenue is $775.3M (range $768.0M – $780.2M). Full-year revenue is projected at $2.4B, growing to $2.4B next year.
Have analysts been upgrading or downgrading GCO lately?+
As of Sep, 0 of 2 firms rate GCO a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their GCO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
